• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ending drug registration apartheid: taming data exclusivity and patent/registration linkage.

作者信息

Baker Brook K

机构信息

Northeastern University School of Law, Program on Human Rights and the Global Economy, USA.

出版信息

Am J Law Med. 2008;34(2-3):303-44. doi: 10.1177/009885880803400209.

DOI:10.1177/009885880803400209
PMID:18697696
Abstract
摘要

相似文献

1
Ending drug registration apartheid: taming data exclusivity and patent/registration linkage.终结药品注册的不平等：抑制数据独占性及专利/注册关联
Am J Law Med. 2008;34(2-3):303-44. doi: 10.1177/009885880803400209.
2
Unfair competition under the TRIPS agreement: protection of data submitted for the registration of pharmaceuticals.《与贸易有关的知识产权协定》下的不正当竞争：用于药品注册所提交数据的保护
Chic J Int Law. 2002 Spring;3(1):69-85.
3
Patent implications in the pharmaceutical industry: Are static high prices leading to dynamic innovations?制药行业中的专利影响：静态高价是否会带来动态创新？
Int J Risk Saf Med. 2019;30(3):179-192. doi: 10.3233/JRS-191008.
4
[Evolution of the international intellectual property rights system: patent protection for the pharmaceutical industry and access to medicines].[国际知识产权体系的演变：制药行业的专利保护与药品可及性]
Cad Saude Publica. 2007 Feb;23(2):257-67. doi: 10.1590/s0102-311x2007000200002.
5
Patent necessity: intellectual property dilemmas in the biotech domain and treatment equity for developing countries.专利必要性：生物技术领域的知识产权困境与发展中国家的治疗公平性
Houst J Int Law. 2002;24(2):227-78.
6
International intellectual property strategies for therapeutic antibodies.治疗性抗体的国际知识产权策略。
MAbs. 2011 Nov-Dec;3(6):596-606. doi: 10.4161/mabs.3.6.17788. Epub 2011 Nov 1.
7
Impact of the World Trade Organization TRIPS agreement on the pharmaceutical industry in Thailand.世界贸易组织《与贸易有关的知识产权协定》对泰国制药业的影响。
Bull World Health Organ. 2001;79(5):461-70.
8
Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?《与贸易有关的知识产权协定》（TRIPS协定）在拉丁美洲和加勒比地区的实施是否产生了有利于公共卫生的知识产权立法？
Bull World Health Organ. 2004 Nov;82(11):815-21. Epub 2004 Dec 14.
9
The Trans-Pacific Partnership Agreement and Implications for Access to Essential Medicines.
JAMA. 2015 Oct 20;314(15):1563-4. doi: 10.1001/jama.2015.10872.
10
USA-Morocco deal may extend drug patents to 30 years.美国与摩洛哥的协议可能将药品专利延长至30年。
Lancet. 2003 Dec 6;362(9399):1904. doi: 10.1016/S0140-6736(03)15006-4.

引用本文的文献

1
Cambodia's Imminent Graduation from Least Developed Country Status: What Will be the Impact of the TRIPS Agreement on Access to HIV and Hepatitis C Medicines in Cambodia?柬埔寨即将脱离最不发达国家地位：TRIPS 协议对柬埔寨获得艾滋病毒和丙型肝炎药物的影响是什么？
Int J Soc Determinants Health Health Serv. 2024 Jul;54(3):295-308. doi: 10.1177/27551938241242602. Epub 2024 Apr 2.
2
Patenting and patent challenges in South Korea after introducing a patent linkage system.韩国引入专利链接制度后的专利申请与专利挑战
Global Health. 2022 Nov 12;18(1):95. doi: 10.1186/s12992-022-00887-5.
3
What is the impact of intellectual property rules on access to medicines? A systematic review.
知识产权规则对药品可及性有何影响？一项系统综述。
Global Health. 2022 Apr 15;18(1):40. doi: 10.1186/s12992-022-00826-4.
4
Perceived impact of the patent linkage system on pharmaceutical market from the viewpoint of the domestic manufacturers in South Korea.从韩国国内制药商的角度来看专利链接制度对药品市场的影响。
Global Health. 2022 Mar 21;18(1):34. doi: 10.1186/s12992-022-00829-1.
5
Patent challenges and factors associated with successful patent challengers under the patent linkage system: recent evidence from South Korea after the Korea United States free trade agreement.专利链接制度下的专利挑战及其与成功专利挑战者的关联因素：韩国《美韩自由贸易协定》后的最新证据
Global Health. 2021 Sep 28;17(1):116. doi: 10.1186/s12992-021-00765-6.
6
Moderating the impact of patent linkage on access to medicines: lessons from variations in South Korea, Australia, Canada, and the United States.调节专利链接对药品可及性的影响：来自韩国、澳大利亚、加拿大和美国差异的经验教训。
Global Health. 2018 Oct 24;14(1):101. doi: 10.1186/s12992-018-0423-0.
7
Data exclusivity exceptions and compulsory licensing to promote generic medicines in the European Union: .欧盟促进仿制药发展的数据独占权例外与强制许可：
J Pharm Policy Pract. 2017 Jun 28;10:19. doi: 10.1186/s40545-017-0107-9. eCollection 2017.
8
Trans-Pacific Partnership Provisions in Intellectual Property, Transparency, and Investment Chapters Threaten Access to Medicines in the US and Elsewhere.《跨太平洋伙伴关系协定》中知识产权、透明度和投资章节的条款威胁到美国及其他地区的药品可及性。
PLoS Med. 2016 Mar 8;13(3):e1001970. doi: 10.1371/journal.pmed.1001970. eCollection 2016 Mar.
9
Obstacles and opportunities to improve antiretroviral regimen access in low-income countries.改善低收入国家获得抗逆转录病毒治疗方案的障碍和机遇。
Curr HIV/AIDS Rep. 2010 Aug;7(3):161-7. doi: 10.1007/s11904-010-0053-5.